Using a rapid test to guide treatment for respiratory infections in the ER
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether using a fast, bedside PCR test (which quickly identifies the virus or bacteria causing your illness) can help doctors choose the right treatment sooner for adults admitted to the hospital with a respiratory infection like pneumonia or flu. It aims to improve care by tailoring antibiotics or antivirals to the specific cause.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are being admitted to the hospital for a sudden respiratory illness like pneumonia, bronchitis, the flu, or a worsening of COPD, asthma, or bronchiectasis
- Your respiratory symptoms started within the last 10 days
- You have not taken any antibiotics or antiviral medications in the past 14 days
- You have not had a positive COVID-19 or flu test (antigen or PCR) before arriving at the ER
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a fast multiplex PCR test (a molecular test that identifies multiple respiratory viruses at once) helps urgent care doctors treat patients with common respiratory illnesses more effectively. The test results are analyzed to see if they improve patient outcomes and reduce unnecessary antibiotics.
This trial is testing a new at-home test for respiratory infections like the flu and COVID-19. The test is done by you or a caregiver using a nose swab. It may help you get quick and accurate results without going to a clinic.
This study is testing different treatments for people with respiratory infections like the flu who are not in the hospital. You may be able to join if you have a positive test, have symptoms like cough or fever, and start within a few days of feeling sick.
This trial evaluates a new test that can detect flu A/B, RSV, and COVID-19 from a single nose swab. It is for people who are currently sick with respiratory symptoms and are either hospitalized, in the ER, visiting a clinic, or living in a long-term care facility.
This trial tests an emergency breathing-related approach for adults with a sudden, community-acquired respiratory infection. It may help doctors quickly sort out what’s going on and guide early care.
This trial compares a fast, new test for lung infections to the usual slower tests. The goal is to see if getting quick results helps doctors choose the right antibiotic or antiviral sooner, which could help you get better faster while in the hospital.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.